eastman kodak &lt;ek> sell holdings eastman kodak plans sell 2.3 pct holding icn pharmaceuticals &lt;icn> part pct holdings viratek &lt;vira>. purpose investments lay groundwork creation nucleic acid research institute. achieved, longer reason maintain equity positions, kodak said. kodak holds 470,000 sahres icn, trading 18-3/4 700,000 viratek, trading 44.